Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 3210

DeLand, FL 32720


Study Summary:

A randomized, double-blind, double dummy, placebo-controlled, crossover study to evaluate the efficacy of TREXIMA versus Butalbital-containing combination medications for the Acute Treatment of Migraine when administered during the moderate-severe pain phase of the Migraine.


Qualified Participants Must:

• Have an active prescription of Fioricet, must be currently using it as their primary treatment of migraines, and must have used the Fioricet to treat at least one migraine within the past 30 days
• Be 18 to 65 years of age
• Must have migraines, and must have had at least two attacks per month in the past 3 months.


Qualified Participants May Receive:

Treatment up to 3 migraine attacks and will be paid up to $220 upon completion of study.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.